Tenax Therapeutics TENX Cash Flow Statement (2009-2026)

NASDAQ TENX
$1.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Tenax Therapeutics Quarterly Cash Flow Statement

Periods 72 quarters
Latest Sep 2026

Tenax Therapeutics reported cash from operations of -$0.01B and free cash flow of -$0.01B for the quarter ended Sep 2026, down 35.6% year over year. This cash flow statement covers 72 quarters of results from Jan 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jan2009 Apr2009 Jul2009 Oct2009 Jan2010 Apr2010 Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-3.21M-2.72M8.30M-14.08M-2.55M-1.41M3.92M-7.00M-3.23M-3.80M-3.58M-3.96M-6.27M-10.41M-10.85M-15.80M-15.54M-15.72M-17.80M-16.70M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.00M0.00M0.00M895.000.00M0.00M0.00M895.000.00M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.03M0.03M0.03M0.03M0.03M
Amortization of Deferred ChargesAmort. Deferred Charges
0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M895.000.00M969.000.01M
Share-based CompensationStock Comp.
0.22M0.08M0.11M0.09M0.09M0.07M0.05M0.04M0.04M0.12M0.01M0.01M0.97M4.14M4.50M5.50M4.79M2.84M2.80M2.40M
Gains from Sales and DivestituresGains Divest
0.00M0.00M0.00M125.00
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.49M0.08M0.03M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.38M0.96M-0.23M-0.20M0.78M-0.04M0.02M-0.68M0.24M0.36M-1.22M
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
-1.00M-0.22M0.71M1.58M-1.32M-1.28M5.05M0.43M0.31M0.45M-0.23M
Change in Accrued ExpensesChange Accrued Exp.
0.10M0.18M-0.39M-0.66M0.53M-0.63M-0.08M-0.06M1.00M-0.48M0.06M0.39M0.56M-0.61M1.04M-0.97M0.12M1.03M-0.86M0.51M
Change in Other Operating AssetsOther Assets Change
-0.17M-0.48M1.26M-0.16M-1.59M0.23M0.20M-0.10M-0.65M-0.02M-0.64M0.24M0.36M-1.22M-0.22M3.05M3.22M-2.24M-0.74M-0.40M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.03M-0.03M-0.03M-0.03M-0.03M
Other Working Capital ChangesOther WC Changes
0.14M0.46M-1.28M0.13M1.56M-0.23M-0.20M0.10M0.65M0.02M0.64M-0.24M-0.36M1.22M0.22M-3.05M-3.22M2.24M0.74M0.40M
Cash from OperationsCash from Ops.
-2.77M-2.94M-3.43M-3.33M-1.69M-1.72M-0.92M-2.08M-1.18M-5.20M-3.00M-3.10M-3.51M-7.00M-6.23M-9.17M-13.40M-9.31M-14.19M-12.44M
Investing Activities
Capital ExpendituresCapex
0.00M0.01M0.00M0.00M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M0.00M157.00
Change in Property, Plant and EquipmentChange in PP&E
0.00M-0.01M0.00M157.00
Change in IntangiblesChange Intangibless
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Cash from Investing ActivitiesCash from Investing
0.00M-0.01M0.00M0.00M0.00M157.00
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.36M0.26M
Long-Term Debt RepaymentsLT Debt Repayment
0.14M0.14M0.09M-0.36M0.11M0.17M0.17M0.17M0.09M0.13M0.28M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.23M-0.14M-0.09M0.62M-0.11M-0.17M-0.17M-0.17M-0.09M-0.13M-0.28M
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
0.23M-0.14M-0.09M0.62M-0.11M-0.17M-0.17M-0.17M-0.09M-0.13M-0.28M
Change in Capital Stock
Common Stock IssuedStock Issued
7.93M-7.93M14.41M0.07M-13.96M-0.51M8.35M-6.52M-1.76M15.30M0.03M0.05M
Net Shares Issued and RepurchasedNet Shares Issued
7.93M-7.93M14.41M0.07M-13.96M-0.51M8.35M-6.52M-1.76M15.30M0.03M0.05M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
7.93M-7.93M14.41M0.07M-13.96M-0.51M0.00M0.00M1.83M-1.76M0.35M0.28M3.06M15.30M30.47M13.37M8.18M
Other financing activities (as filed)
-0.28M-0.34M
Cash from Financing ActivitiesCash from Financing
0.23M7.79M-0.09M0.00M14.01M-0.10M-0.17M-0.17M7.92M-0.13M92.01M0.07M23.56M0.28M3.06M11.61M30.50M13.37M8.23M
Additional items
Change in Cash
-2.77M-2.72M4.36M-3.42M-1.68M12.29M-1.02M-2.25M-1.35M2.76M-3.17M88.93M-3.46M16.60M-5.99M-6.09M-1.80M21.19M-0.78M-4.25M
Ending Cash Balance
5.58M2.87M7.23M3.81M2.12M14.41M13.39M2,123.68M2.12M9.79M9.79M9.79M9.79M94.85M94.85M94.85M94.85M97.57M97.57M97.57M
Free Cash FlowFCF
-2.77M-2.94M-3.43M-3.33M-1.68M-1.73M-0.92M-2.08M-1.18M-5.20M-3.00M-3.10M-3.51M-7.00M-6.23M-9.17M-13.40M-9.31M-14.19M-12.44M
Net Cash FlowNCF
-2.77M-2.72M4.36M-3.42M-1.68M12.29M-1.02M-2.25M-1.35M2.72M-3.13M88.91M-3.44M16.56M-5.95M-6.11M-1.79M21.19M-0.82M-4.21M
Interest Paid
0.00M0.01M0.01M0.01M
Income Taxes PaidTaxes Paid

Tenax Therapeutics Cash Flow Statement API

Pull Tenax Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TENX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY